Response Genetics has named Stephanie Astrow as vice president of research and development.
Astrow most recently was scientific director for oncology at Quest Diagnostics, where she worked to introduce new assays and services and coordinated with pharmaceutical companies to develop companion diagnostics. She also served as vice president and director of oncology at Pathway Diagnostics and vice president and scientific director at Impath.
Knome has appointed Hugh Reinhoff to its scientific advisory board.
Reinhoff is currently a managing director of Life Science Venture Partners, an adjunct scientist at the Children's Hospital Oakland Research Institute, and CEO of FerroKin BioSciences.
Reinhoff founded the nonprofit MyDaughtersDNA.org, and previously served as CEO and chairman of the board at DNA Sciences. He was also founding director of Healtheon, now known as WebMD Health. He holds an MD from the Johns Hopkins University School of Medicine.